Eisai
4523.T
#1921
Rank
$8.40 B
Marketcap
$29.82
Share price
-0.56%
Change (1 day)
-42.09%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : $3.26 Billion USD

According to Eisai's latest financial reports the company's total liabilities are $3.26 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31$3.30 B-13.68%
2022-03-31$3.83 B16.79%
2021-03-31$3.28 B-1.36%
2020-03-31$3.32 B-11.96%
2019-03-31$3.77 B-7.61%
2018-03-31$4.09 B6.8%
2017-03-31$3.83 B8.38%
2016-03-31$3.53 B-6.1%
2015-03-31$3.76 B-12.85%
2014-03-31$4.31 B-21.07%
2013-03-31$5.47 B-21.98%
2012-03-31$7.01 B-8.29%
2011-03-31$7.64 B5.15%
2010-03-31$7.27 B0.66%
2009-03-31$7.22 B7.66%
2008-03-31$6.71 B244.51%
2007-03-31$1.94 B0.61%
2006-03-31$1.93 B2.14%
2005-03-31$1.89 B0.63%
2004-03-31$1.88 B9.26%
2003-03-31$1.72 B23.34%
2002-03-31$1.39 B-13.02%
2001-03-31$1.60 B